Rankings are calculated based on verified user reviews, recency of updates, and community voting weighted by user reputation score.
No tags available
David Baker is a computational biologist known for his development of the Rosetta software suite, which predicts protein structures from their amino acid sequences. Rosetta has revolutionized structur...
Peter G. Schultz is a prominent figure in synthetic biology and molecular chemistry. His research has focused on the development of new methods for drug discovery and the synthesis of complex molecule...
Atomwise utilizes deep learning for structure-based drug design, primarily through virtual screening. Their AtomNet technology predicts the binding affinity of small molecules to protein structures, e...
Recursion Pharmaceuticals uses high-content imaging and machine learning to build a massive phenotypic screening platform. They generate vast datasets of cellular responses to various compounds and us...
Valo Health's platform integrates data from various sources genomics, clinical trials, and real-world evidence to accelerate drug discovery and development. Their Maestro platform uses AI to predict...
Synergy BioSciences is a research-focused pharmaceutical company working on novel therapeutic approaches. They are in the early stages of drug discovery and have limited clinical data. SYBIs market ca...
You're subscribed! We'll notify you about new drug-discovery.